跳至主要内容
临床试验/NCT00255814
NCT00255814已完成1 期

A Phase I Trial of Highly Conformal Radiation Therapy for Patients With Liver Metastases

Radiation Therapy Oncology Group6 个研究点 分布在 2 个国家目标入组 26 人开始时间: 2005年11月最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
26
试验地点
6
主要终点
To determine the maximally tolerated dose

研究概览

简要总结

RATIONALE: Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue.

PURPOSE: This phase I trial is studying the side effects and best dose of radiation therapy in treating patients with liver metastases.

详细描述

OBJECTIVES:

Primary

  • Determine the maximum tolerated dose of high dose per fraction, highly conformal radiotherapy in patients with liver metastases.

Secondary

  • Determine the failure patterns and survival of patients treated with this regimen.
  • Correlate dose-volume characteristics with possible toxic effects of this regimen in these patients.
  • Determine the local control rate within irradiated fields in patients treated with this regimen.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

To determine the maximally tolerated dose

时间窗: From start of treatment to 90 days

次要结局

未报告次要终点

研究者

申办方类型
Network
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验

已完成
2 期
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for EpendymomaCentral Nervous System TumorBrain Tumor
NCT00027846Children's Oncology Group378
已完成
1 期
Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer And Lung DysfunctionLung Cancer
NCT00009789Alliance for Clinical Trials in Oncology39
终止
1 期
Phase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCCSalivary Gland Squamous Cell CarcinomaStage II Salivary Gland CancerStage II Squamous Cell Carcinoma of the HypopharynxStage II Squamous Cell Carcinoma of the Lip and Oral CavityStage II Squamous Cell Carcinoma of the OropharynxStage II Verrucous Carcinoma of the Oral CavityStage III Salivary Gland CancerStage III Squamous Cell Carcinoma of the HypopharynxStage III Squamous Cell Carcinoma of the Lip and Oral CavityStage III Squamous Cell Carcinoma of the OropharynxStage III Verrucous Carcinoma of the Oral CavityStage IV Salivary Gland CancerStage IV Squamous Cell Carcinoma of the HypopharynxStage IV Squamous Cell Carcinoma of the Lip and Oral CavityStage IV Squamous Cell Carcinoma of the OropharynxStage IV Verrucous Carcinoma of the Oral Cavity
NCT01283178Virginia Commonwealth University3
已完成
1 期
Radiation Therapy, Docetaxel, and Hormone Therapy in High-Risk Locally Advanced Metastasized Prostate CancerProstate Cancer
NCT00482807University of Nebraska9
Unknown
1 期
Radiation Therapy, Irinotecan, and Cetuximab in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Rectal CancerColorectal Cancer
NCT00392470Centre Hospitalier Universitaire Vaudois20